Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 28.688 |
|
|||||
| News | - | ||||||
| Tageshoch | 0,714 | Niedrig Hoch |
|||||
| Tagestief | 0,6516 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Alzamend Neuro Inc | ALZN | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,021 | -3,04% | 0,67 | 01:59:03 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,714 | 0,6516 | 0,714 | 0,6755 | 0,691 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 158 | 28.688 | US$ 0,6857158 | US$ 19.672 | - | 0,6516 - 11,91 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:59:03 | formt | 702 | US$ 0,67 | USD |
Finanzwerte ALZN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 4,77M | 7,12M | - | 0 | -14,88M | -2,09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Alzamend Neuro
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 07.3.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02.2.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.1.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.12.2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11.12.2023 | 14:00 | Business Wire | Alzamend Neuro Receives FDA “Study May Proceed” Notification.. |
| 20.11.2023 | 14:00 | Business Wire | Alzamend Neuro Receives FDA “Study May Proceed” Notification.. |
| 16.11.2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16.11.2023 | 14:00 | Business Wire | Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid.. |
| 13.11.2023 | 14:00 | Business Wire | Alzamend Neuro Submits IND Application for a Phase IIA.. |
| 30.10.2023 | 21:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30.10.2023 | 13:00 | Business Wire | Alzamend Neuro Announces Reverse Stock Split |
| 23.10.2023 | 14:00 | Business Wire | Alzamend Neuro Submits IND Application for a Phase IIA.. |
Forum Alzamend Neuro
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ALZN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,90 | 0,90 | 0,6516 | 0,7489771 | 55.727 | -0,23 | -25,56% |
| 1 Monat | 1,07 | 1,07 | 0,6516 | 0,8738055 | 50.163 | -0,40 | -37,38% |
| 3 Monate | 0,93 | 1,29 | 0,6516 | 1,00 | 58.167 | -0,26 | -27,96% |
| 6 Monate | 3,0315 | 3,2985 | 0,6516 | 1,43 | 121.955 | -2,36 | -77,90% |
| 1 Jahr | 8,325 | 11,91 | 0,6516 | 4,37 | 153.795 | -7,66 | -91,95% |
| 3 Jahre | 435,00 | 503,25 | 0,6516 | 41,99 | 1.229.723 | -434,33 | -99,85% |
| 5 Jahre | 435,00 | 503,25 | 0,6516 | 41,99 | 1.229.723 | -434,33 | -99,85% |
